Fairfax Station, VA, United States of America

Mohamad Gabriel Alameh

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohamad Gabriel Alameh: Innovator in Lipid Nanoparticle Manufacturing

Introduction

Mohamad Gabriel Alameh is a notable inventor based in Fairfax Station, Virginia. He has made significant contributions to the field of lipid nanoparticle manufacturing, particularly in enhancing the potency of nucleic acid delivery systems. His innovative approaches have the potential to revolutionize pharmaceutical applications.

Latest Patents

Alameh holds a patent titled "Methods of lipid nanoparticle manufacture and compositions derived therefrom." This patent discloses methods for increasing the potency of nucleic acid loaded lipid nanoparticles (naLNPs) through novel manufacturing techniques. The methods described in the patent address major technical challenges and high costs associated with previous LNP manufacturing techniques. By improving the industrial production of LNPs, Alameh's invention provides more potent naLNPs for nucleic acid delivery. Specifically, the methods show increased potency due to enhanced mixing concentration of lipids and mRNA during assembly.

Career Highlights

Throughout his career, Alameh has worked with prestigious institutions, including the University of Pennsylvania and George Mason Research Foundation, Inc. His experience in these organizations has contributed to his expertise in lipid nanoparticle technology and its applications in medicine.

Collaborations

Alameh has collaborated with notable colleagues, including Michael Daro Buschmann and Mikell Paige. These partnerships have furthered his research and development efforts in the field of lipid nanoparticles.

Conclusion

Mohamad Gabriel Alameh is a pioneering inventor whose work in lipid nanoparticle manufacturing is paving the way for advancements in nucleic acid delivery systems. His innovative methods and collaborations highlight his commitment to improving pharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…